BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | -15.02%365.71M | 0.67%1.8B | -7.09%1.25B | 1.25%873.77M | 2.35%430.37M | 1.89%1.78B | 1.27%1.34B | 1.82%862.95M | 3.05%420.49M | 2.62%1.75B |
Operating revenue | -15.02%365.71M | 0.67%1.8B | -7.09%1.25B | 1.25%873.77M | 2.35%430.37M | 1.89%1.78B | 1.27%1.34B | 1.82%862.95M | 3.05%420.49M | 2.62%1.75B |
Other operating revenue | ---- | -1.91%22.73M | ---- | 37.52%13.83M | ---- | -24.95%23.17M | ---- | -26.76%10.06M | ---- | -7.25%30.87M |
Total operating cost | -2.64%361.2M | 4.56%1.7B | -4.36%1.1B | 1.29%758.56M | 1.17%370.99M | 4.05%1.62B | -0.53%1.15B | 0.92%748.93M | 2.24%366.72M | -0.36%1.56B |
Operating cost | -4.58%320.21M | 5.13%1.49B | -6.57%987.39M | -0.62%684.14M | 0.26%335.57M | 1.61%1.42B | -2.27%1.06B | -0.80%688.42M | -0.09%334.7M | 1.08%1.39B |
Operating tax surcharges | -47.18%616.91K | 20.44%6.54M | 12.42%3.14M | 25.99%2.41M | 32.99%1.17M | -26.89%5.43M | -40.28%2.79M | -24.47%1.91M | -46.66%878.16K | 35.05%7.43M |
Operating expense | 94.89%6.22M | -2.14%26.56M | -10.94%11.14M | -13.42%7.22M | -21.75%3.19M | 4.38%27.14M | -7.78%12.51M | -6.22%8.34M | -2.94%4.08M | -6.43%26M |
Administration expense | 20.83%21.74M | -5.18%101.43M | 9.89%61.35M | 1.04%39M | -15.66%17.99M | 11.23%106.97M | 11.77%55.83M | 19.28%38.6M | 33.17%21.33M | -5.08%96.17M |
Financial expense | 2.62%-6.65M | -8.97%-28.42M | -23.34%-22.13M | -28.48%-15.04M | -12.02%-6.83M | -11.20%-26.08M | -9.62%-17.94M | -9.27%-11.71M | -14.98%-6.1M | -25.88%-23.45M |
-Interest expense (Financial expense) | -2.69%603.01K | 1.23%2.58M | 0.63%1.89M | -0.19%1.26M | -3.10%619.71K | 0.85%2.55M | -1.50%1.88M | -1.58%1.26M | -1.15%639.5K | -5.06%2.53M |
-Interest Income (Financial expense) | 2.07%-7.38M | -8.39%-31.59M | -20.82%-24.36M | -25.66%-16.48M | -10.92%-7.53M | -8.24%-29.14M | -7.47%-20.16M | -6.67%-13.12M | -12.51%-6.79M | -18.18%-26.92M |
Research and development | -4.23%19.06M | 9.36%101.21M | 43.93%61.58M | 74.71%40.83M | 68.33%19.9M | 56.29%92.54M | 66.04%42.79M | 55.70%23.37M | 65.88%11.82M | -15.23%59.21M |
Credit Impairment Loss | -248.80%-622.75K | 144.26%1.77M | 947.30%2.85M | 482.79%1.8M | 237.88%418.5K | -9,851.51%-4.01M | -22.71%-336.42K | -55.80%-469.95K | -274.24%-303.53K | -103.26%-40.26K |
Asset Impairment Loss | 53.91%-620.02K | -113.42%-2.95M | -38.03%-5.13M | 12.74%-2.91M | -41.71%-1.35M | 221.79%21.97M | 7.94%-3.72M | -257.83%-3.33M | -298.26%-949.35K | -183.67%-18.04M |
Other net revenue | -50.43%1.03M | 0.66%39.14M | -11.58%15.6M | -23.47%8.56M | -59.41%2.08M | 204.21%38.88M | -7.25%17.65M | -26.15%11.19M | -23.56%5.12M | -64.05%12.78M |
Invest income | -36.09%1.33M | 42.85%21.18M | -41.03%11.4M | -36.91%8.45M | -60.24%2.08M | -33.72%14.83M | 13.31%19.33M | 11.91%13.4M | 40.61%5.24M | 2.21%22.37M |
-Including: Investment income associates | -36.09%1.33M | 42.85%21.18M | -41.03%11.4M | -36.91%8.45M | -60.24%2.08M | -33.72%14.83M | 13.31%19.33M | 11.91%13.4M | 40.61%5.24M | 2.21%22.37M |
Asset deal income | 189.63%12.41K | 107.81%82.74K | 36.73%-31.5K | 183.15%14.98K | -139.44%-13.84K | -1,886.85%-1.06M | 55.73%-49.79K | 1.30%-18.02K | 41.68%-5.78K | -436.20%-53.31K |
Other revenue | -0.51%927.08K | 166.56%19.05M | 169.17%6.52M | -25.17%1.2M | -17.57%931.82K | -16.35%7.15M | -62.12%2.42M | -63.68%1.61M | -65.66%1.13M | -54.48%8.54M |
Operating profit | -90.99%5.54M | -30.74%139.27M | -22.71%159.33M | -1.14%123.77M | 4.35%61.45M | -1.96%201.08M | 11.67%206.15M | 3.86%125.2M | 5.10%58.89M | 15.52%205.1M |
Add:Non operating Income | 2,328.51%81.13K | 105.41%391.89K | 5,469.95%390K | -6.28%6.56K | 927,836.11%3.34K | 148.30%190.78K | 600.19%7K | 600.04%7K | --0.36 | -97.04%76.84K |
Less:Non operating expense | ---- | 6.14%530.74K | 6.15%530.74K | -99.96%200 | ---- | -50.00%500.01K | -50.00%500K | -50.00%500K | ---- | 0.00%1M |
Total profit | -90.86%5.62M | -30.70%139.13M | -22.59%159.19M | -0.75%123.78M | 4.36%61.46M | -1.67%200.77M | 12.01%205.66M | 4.32%124.71M | 5.10%58.89M | 13.98%204.18M |
Less:Income tax cost | -85.92%904.85K | -9.07%9.9M | -15.93%17M | -3.82%12.01M | 18.36%6.43M | -50.92%10.89M | -6.87%20.22M | -8.56%12.49M | -14.73%5.43M | -0.86%22.19M |
Net profit | -91.44%4.71M | -31.94%129.23M | -23.32%142.2M | -0.41%111.77M | 2.93%55.03M | 4.33%189.88M | 14.54%185.44M | 5.98%112.22M | 7.64%53.46M | 16.09%181.99M |
Net profit from continuing operation | -91.44%4.71M | -31.94%129.23M | -23.32%142.2M | -0.41%111.77M | 2.93%55.03M | 4.33%189.88M | 14.54%185.44M | 5.98%112.22M | 7.64%53.46M | 16.09%181.99M |
Less:Minority Profit | 420.17%208.69K | 203.43%1.61M | -5.99%233.03K | ---- | ---65.18K | --532.14K | --247.88K | ---- | ---- | ---- |
Net profit of parent company owners | -91.83%4.5M | -32.60%127.61M | -23.34%141.96M | -0.41%111.77M | 3.06%55.09M | 4.04%189.34M | 14.39%185.19M | 5.98%112.22M | 7.64%53.46M | 16.09%181.99M |
Earning per share | ||||||||||
Basic earning per share | -92.02%0.0119 | -32.94%0.3438 | -23.70%0.3827 | -0.76%0.3015 | 2.54%0.1492 | 3.49%0.5127 | 13.84%0.5016 | 5.60%0.3038 | 6.91%0.1455 | 15.50%0.4954 |
Diluted earning per share | -91.85%0.0121 | -32.70%0.3439 | -23.04%0.3828 | 0.00%0.3016 | 2.63%0.1485 | 3.32%0.511 | 12.94%0.4974 | 4.58%0.3016 | 6.79%0.1447 | 15.75%0.4946 |
Other composite income | ||||||||||
Total composite income | -91.44%4.71M | -31.94%129.23M | -23.32%142.2M | -0.41%111.77M | 2.93%55.03M | 4.33%189.88M | 14.54%185.44M | 5.98%112.22M | 7.64%53.46M | 16.09%181.99M |
Total composite income of parent company owners | -91.83%4.5M | -32.60%127.61M | -23.34%141.96M | -0.41%111.77M | 3.06%55.09M | 4.04%189.34M | 14.39%185.19M | 5.98%112.22M | 7.64%53.46M | 16.09%181.99M |
Total composite income of minority owners | 420.17%208.69K | 203.43%1.61M | -5.99%233.03K | ---- | ---65.18K | --532.14K | --247.88K | ---- | ---- | ---- |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.